Home > Qtrly Results > GLAND PHARMA

GLAND PHARMA
Quarterly Results Analysis [Sep2026]

GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Quarterly Results

Consolidated Sep2026
UnAudited
Jun2026
UnAudited
Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Revenues ₹1,834 Cr ₹1,800 Cr ₹1,743 Cr ₹1,695 Cr ₹1,487 Cr ₹1,506 Cr ₹1,425 Cr ₹1,384 Cr
Expenses ₹1,350 Cr ₹1,311 Cr ₹1,230 Cr ₹1,260 Cr ₹1,173 Cr ₹1,138 Cr ₹1,077 Cr ₹1,024 Cr
Operating Income ₹484 Cr ₹489 Cr ₹513 Cr ₹435 Cr ₹314 Cr ₹368 Cr ₹348 Cr ₹360 Cr
Other Income ₹69 Cr ₹61 Cr ₹111 Cr ₹63 Cr ₹84 Cr ₹58 Cr ₹44 Cr ₹58 Cr
Interest ₹7 Cr ₹4 Cr ₹10 Cr ₹4 Cr ₹8 Cr ₹11 Cr ₹7 Cr ₹23 Cr
Depreciation ₹115 Cr ₹111 Cr ₹109 Cr ₹108 Cr ₹106 Cr ₹101 Cr ₹96 Cr ₹96 Cr
Profit Before Tax ₹431 Cr ₹435 Cr ₹506 Cr ₹362 Cr ₹284 Cr ₹313 Cr ₹288 Cr ₹299 Cr
Profit After Tax ₹291 Cr ₹317 Cr ₹367 Cr ₹261 Cr ₹184 Cr ₹215 Cr ₹187 Cr ₹205 Cr
EPS ₹17.62 ₹19.21 ₹22.26 ₹15.87 ₹11.15 ₹13.08 ₹11.32 ₹12.42
Industry Peers & Returns1W1M1Y
GLAND PHARMA 4.6% 7.8% 63.4%
SUN PHARMACEUTICAL INDUSTRIES 7.3% 8.4% 13.1%
DIVIS LABORATORIES 15.3% 24.1% 63%
TORRENT PHARMACEUTICALS 1% 2.5% 33.4%
CIPLA 0.4% 7.9% -6.2%
DR REDDYS LABORATORIES 1% 15.9% 14%
MANKIND PHARMA 5.1% 12.3% 8.8%
LUPIN -0.2% 2.7% -0.2%
ZYDUS LIFESCIENCES 1.9% 8.8% 23.4%

GLAND PHARMA Quarterly Revenues

Revenues
Q-o-Q

1.85 %

Y-o-Y

23.32 %

Quarters Revenues % Change
Sep2026 ₹1,834 Cr
1.85
Jun2026 ₹1,800 Cr
3.30
Mar2026 ₹1,743 Cr
2.80
Dec2025 ₹1,695 Cr
14.02
Sep2025 ₹1,487 Cr
-1.25
Jun2025 ₹1,506 Cr
5.66
Mar2025 ₹1,425 Cr
2.95
Dec2024 ₹1,384 Cr -

GLAND PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

-1.09 %

Y-o-Y

54.21 %

Quarters Operating Profit % Change
Sep2026 ₹484 Cr
-1.09
Jun2026 ₹489 Cr
-4.61
Mar2026 ₹513 Cr
17.97
Dec2025 ₹435 Cr
38.55
Sep2025 ₹314 Cr
-14.65
Jun2025 ₹368 Cr
5.83
Mar2025 ₹348 Cr
-3.46
Dec2024 ₹360 Cr -
Operating Margins
Q-o-Q

-2.87 %

Y-o-Y

25.06 %

Quarters Operating Margin% % Change
Sep2026 26.4%
-2.87
Jun2026 27.18%
-7.68
Mar2026 29.44%
14.78
Dec2025 25.65%
21.51
Sep2025 21.11%
-13.59
Jun2025 24.43%
0.16
Mar2025 24.39%
-6.23
Dec2024 26.01% -

GLAND PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-8.27 %

Y-o-Y

58.29 %

Quarters Profit After Tax % Change
Sep2026 ₹291 Cr
-8.27
Jun2026 ₹317 Cr
-13.56
Mar2026 ₹367 Cr
40.23
Dec2025 ₹261 Cr
42.35
Sep2025 ₹184 Cr
-14.76
Jun2025 ₹215 Cr
15.51
Mar2025 ₹187 Cr
-8.87
Dec2024 ₹205 Cr -
PAT Margins
Q-o-Q

-9.94 %

Y-o-Y

28.42 %

Quarters PAT Margin(%) % Change
Sep2026 15.86 %
-9.94
Jun2026 17.61 %
-16.30
Mar2026 21.04 %
36.45
Dec2025 15.42 %
24.86
Sep2025 12.35 %
-13.70
Jun2025 14.31 %
9.32
Mar2025 13.09 %
-11.49
Dec2024 14.79 % -

GLAND PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-8.28 %

Y-o-Y

58.03 %

Quarters EPS % Change
Sep2026 ₹17.62
-8.28
Jun2026 ₹19.21
-13.70
Mar2026 ₹22.26
40.26
Dec2025 ₹15.87
42.33
Sep2025 ₹11.15
-14.76
Jun2025 ₹13.08
15.55
Mar2025 ₹11.32
-8.86
Dec2024 ₹12.42 -

You may also like the below Video Courses